• Neticonazole Hydrochloride: Imidazole Antifungal for Researc

  2026-04-22

  Neticonazole Hydrochloride stands out as a dual-action imidazole antifungal, offering practical solutions in fungal and colorectal cancer research. Its robust solubility, validated apoptosis induction, and exosome pathway inhibition enable reproducible workflows and effective troubleshooting across microbiology and oncology applications.

• Acridine Orange Hydrochloride: Technical Guide for Nucleic A

  2026-04-21

  Acridine Orange hydrochloride enables precise DNA and RNA discrimination in cell-based assays through differential fluorescence, offering critical value in cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is best suited to workflows requiring robust, real-time nucleic acid visualization, but is not recommended where long-term solution stability or protein-specific targeting is required.

• ECL Western Blotting Substrate: Technical Use and Guidance

  2026-04-21

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase (HRP) in protein analysis workflows. It is best applied in chemiluminescent Western blot assays for research in molecular biology, cancer biology, and signal transduction. This substrate is not compatible with fluorescent or radioisotopic detection methods.

• Olaparib (AZD2281) Workflows: Localized Delivery & Radiosens

  2026-04-20

  Olaparib (AZD2281) is redefining DNA damage response assays and tumor radiosensitization studies, particularly in BRCA-deficient and brain tumor models. Explore advanced workflow enhancements, troubleshooting strategies, and the practical impact of nanoparticle-based localized delivery, as highlighted in cutting-edge preclinical research.

• Z-VDVAD-FMK: Advanced Caspase-2 Inhibition for Apoptosis Pat

  2026-04-20

  Explore how Z-VDVAD-FMK enables high-resolution dissection of caspase-2-driven apoptotic pathways in cell biology and viral-host interactions. This article uniquely bridges mechanistic details with recent antiviral insights, offering advanced guidance for apoptosis assay design.

• Ceftazidime in Multidrug Resistance: Beyond Genomics and Pro

  2026-04-19

  Explore the pivotal role of Ceftazidime, a third-generation cephalosporin, in confronting multidrug-resistant Gram-negative infections. This article uniquely bridges recent epidemiological findings with advanced assay strategy for respiratory infection research.

• Itraconazole: Triazole Antifungal Agent in Biofilm Research

  2026-04-18

  Itraconazole from APExBIO redefines antifungal research by enabling robust, reproducible workflows for dissecting biofilm resistance and CYP3A4-mediated interactions. Discover optimized protocols, critical troubleshooting, and strategic insights for tackling multidrug-resistant Candida using validated triazole antifungal workflows.

• Reserpine (N1867): Protocol Guidance for Neuropharmacology R

  2026-04-17

  Reserpine (SKU N1867) addresses the need for high-purity, reproducible standards in neurotransmitter depletion and neuropharmacology research. It is most effectively used in controlled laboratory protocols where its solubility, stability, and handling requirements are rigorously observed. This product is not suitable for diagnostic or clinical applications due to its research-only designation.

• METTL14-m6A Axis Modulates Ulcerative Colitis via lncRNA Pat

  2026-04-16

  Wu et al. (2024) elucidate how METTL14-mediated m6A RNA methylation regulates inflammation in ulcerative colitis by modulating the DHRS4-AS1/miR-206/A3AR axis. Their findings provide new mechanistic insight into epigenetic control of intestinal inflammation, highlighting METTL14 as a potential therapeutic target.

• Optimizing CYP2C19 Assays with (S)-Mephenytoin (SKU C3414)

  2026-04-15

  (S)-Mephenytoin (SKU C3414) is a rigorously characterized CYP2C19 substrate that addresses reproducibility and sensitivity gaps in in vitro drug metabolism studies. This article presents scenario-driven guidance for biomedical researchers, linking real-world assay challenges to validated solutions with (S)-Mephenytoin from APExBIO.

• HIF-1 Pathway Activation Reduces Ferroptosis via Sphingolipi

  2026-04-14

  Liu et al. reveal that pharmacological inhibition of sphingolipid synthesis by myriocin robustly suppresses ferroptosis in neuronal cells by activating the HIF-1 pathway and stabilizing HIF1α protein. This mechanistic insight advances our understanding of regulated cell death in neurodegeneration and highlights HIF-1 signaling as a potential therapeutic target.

• Causal Roles of CLEC5A and ISG20 in Atherosclerosis Revealed

  2026-04-13

  Zhang et al. integrate Mendelian randomization and eQTL analyses to identify CLEC5A and ISG20 as key drivers of atherosclerosis. Their findings, validated in both patient samples and experimental models, position ISG20 as a promising therapeutic target for atherosclerosis intervention.

• Necroptosis in Lung Epithelial Cells Triggered by Ricin and

  2026-04-12

  Kempen et al. (2023) uncover a novel pathway of bystander necroptosis in lung epithelial cells following ricin toxin exposure, mediated by inflammatory cytokines and HMGB1. This work refines our understanding of toxin-induced lung injury and highlights distinct cell death mechanisms relevant for apoptosis inhibition and translational research.

• Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer

  2026-04-12

  This article critically examines a recent study exploring the role of mitochondrial apoptotic and necroptotic pathways in skeletal muscle atrophy during ovarian cancer progression. Using a robust mouse model and mitochondrial-targeted antioxidant SkQ1, the research interrogates the causal relationships between oxidative stress, caspase activity, and muscle degeneration, offering nuanced insight into cell death mechanisms and the limits of antioxidant intervention.

• Pomalidomide (CC-4047): Optimizing Workflows in Hematologica

  2026-04-11

  Pomalidomide (CC-4047) delivers precision modulation of the tumor microenvironment and cytokine signaling, empowering advanced research in multiple myeloma and erythroid differentiation. This guide details actionable protocols, troubleshooting insights, and practical takeaways for reproducible, data-driven results with APExBIO's trusted reagent.

465 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page